| The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis CE Massie, A Lynch, A Ramos‐Montoya, J Boren, R Stark, L Fazli, ... The EMBO journal 30 (13), 2719-2733, 2011 | 698 | 2011 |
| Androgen receptor pathway-independent prostate cancer is sustained through FGF signaling EG Bluemn, IM Coleman, JM Lucas, RT Coleman, S Hernandez-Lopez, ... Cancer cell 32 (4), 474-489. e6, 2017 | 592 | 2017 |
| Effects of intermittent androgen suppression on androgen‐dependent tumors. Apoptosis and serum prostate‐specific antigen K Akakura, N Bruchovsky, SL Goldenberg, PS Rennie, AR Buckley, ... Cancer 71 (9), 2782-2790, 1993 | 519 | 1993 |
| Inhibition of nuclear hormone receptor activity by calreticulin S Dedhar, PS Rennie, M Shago, CYL Hagesteijn, H Yang, J Filmus, ... Nature 367 (6462), 480-483, 1994 | 459 | 1994 |
| Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma N Bruchovsky, PS Rennie, AJ Coldman, S Larry Goldenberg, M To, ... Cancer research 50 (8), 2275-2282, 1990 | 432 | 1990 |
| Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene. PS Rennie, N Bruchovsky, KJ Leco, PC Sheppard, SA McQueen, ... Molecular Endocrinology 7 (1), 23-36, 1993 | 403 | 1993 |
| The role of hepatocyte nuclear factor-3α (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes N Gao, J Zhang, MA Rao, TC Case, J Mirosevich, Y Wang, R Jin, A Gupta, ... Molecular endocrinology 17 (8), 1484-1507, 2003 | 313 | 2003 |
| Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity A Zoubeidi, A Zardan, E Beraldi, L Fazli, R Sowery, P Rennie, C Nelson, ... Cancer research 67 (21), 10455-10465, 2007 | 301 | 2007 |
| Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer H Miyake, C Nelson, PS Rennie, ME Gleave Cancer research 60 (1), 170-176, 2000 | 295 | 2000 |
| Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour model N Sato, ME Gleave, N Bruchovsky, PS Rennie, SL Goldenberg, PH Lange, ... The Journal of steroid biochemistry and molecular biology 58 (2), 139-146, 1996 | 279 | 1996 |
| Determinants of DNA sequence specificity of the androgen, progesterone, and glucocorticoid receptors: evidence for differential steroid receptor response elements CC Nelson, SC Hendy, RJ Shukin, H Cheng, N Bruchovsky, BF Koop, ... Molecular endocrinology 13 (12), 2090-2107, 1999 | 258 | 1999 |
| Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer M Asim, F Tarish, HI Zecchini, K Sanjiv, E Gelali, CE Massie, A Baridi, ... Nature communications 8 (1), 374, 2017 | 251 | 2017 |
| Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models H Miyake, C Nelson, PS Rennie, ME Gleave Cancer research 60 (9), 2547-2554, 2000 | 248 | 2000 |
| Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer … N Sato, MD Sadar, N Bruchovsky, F Saatcioglu, PS Rennie, S Sato, ... Journal of Biological Chemistry 272 (28), 17485-17494, 1997 | 248 | 1997 |
| Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients N Lallous, SV Volik, S Awrey, E Leblanc, R Tse, J Murillo, K Singh, ... Genome biology 17, 1-15, 2016 | 219 | 2016 |
| The androgen receptor can promote β-catenin nuclear translocation independently of adenomatous polyposis coli DJ Mulholland, H Cheng, K Reid, PS Rennie, CC Nelson Journal of Biological Chemistry 277 (20), 17933-17943, 2002 | 210 | 2002 |
| Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation … H Miyake, C Nelson, PS Rennie, ME Gleave Endocrinology 141 (6), 2257-2265, 2000 | 198 | 2000 |
| Standard treatments induce antigen-specific immune responses in prostate cancer NJ Nesslinger, RA Sahota, B Stone, K Johnson, N Chima, C King, ... Clinical Cancer Research 13 (5), 1493-1502, 2007 | 196 | 2007 |
| Intermittent androgen suppression for prostate cancer: rationale and clinical experience M Gleave, SL Goldenberg, N Bruchovsky, P Rennie Prostate cancer and prostatic diseases 1 (6), 289-296, 1998 | 190 | 1998 |
| IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling X Sheng, HZ Nenseth, S Qu, OF Kuzu, T Frahnow, L Simon, S Greene, ... Nature communications 10 (1), 323, 2019 | 184 | 2019 |
